Žilinskas, J.; Stukas, D.; Jasukaitienė, A.; Žievytė, I.; Balion, Z.; Šapauskienė, J.; Banienė, R.; Paužas, H.; Lizdenis, P.; Čėsna, V.;
et al. Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo. Medicina 2024, 60, 142.
https://doi.org/10.3390/medicina60010142
AMA Style
Žilinskas J, Stukas D, Jasukaitienė A, Žievytė I, Balion Z, Šapauskienė J, Banienė R, Paužas H, Lizdenis P, Čėsna V,
et al. Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo. Medicina. 2024; 60(1):142.
https://doi.org/10.3390/medicina60010142
Chicago/Turabian Style
Žilinskas, Justas, Darius Stukas, Aldona Jasukaitienė, Inga Žievytė, Zbigniev Balion, Jurgita Šapauskienė, Rasa Banienė, Henrikas Paužas, Paulius Lizdenis, Vaidotas Čėsna,
and et al. 2024. "Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo" Medicina 60, no. 1: 142.
https://doi.org/10.3390/medicina60010142
APA Style
Žilinskas, J., Stukas, D., Jasukaitienė, A., Žievytė, I., Balion, Z., Šapauskienė, J., Banienė, R., Paužas, H., Lizdenis, P., Čėsna, V., Dambrauskas, Ž., Gulbinas, A., & Tamelis, A.
(2024). Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo. Medicina, 60(1), 142.
https://doi.org/10.3390/medicina60010142
